Literature DB >> 17457585

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

James C Sisson, Anca M Avram, Domenico Rubello, Milton D Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17457585     DOI： 10.1007/s00259-007-0419-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  14 in total

1.  Use of thyroid ultrasound volume in calculating radioactive iodine dose in hyperthyroidism.

Authors:  K J Lucas
Journal:  Thyroid       Date:  2000-02       Impact factor: 6.568

2.  Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study.

Authors:  H Peters; C Fischer; U Bogner; C Reiners; H Schleusener
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

Review 3.  Protection of the patient in nuclear medicine.

Authors: 
Journal:  Ann ICRP       Date:  1987

4.  Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.

Authors:  A Allahabadia; J Daykin; M C Sheppard; S C Gough; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

5.  Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary?

Authors:  L Bajnok; E Mezosi; E Nagy; J Szabo; I Sztojka; J Varga; L Galuska; A Leovey
Journal:  Thyroid       Date:  1999-09       Impact factor: 6.568

6.  Long-term follow-up study of radioiodine treatment of hyperthyroidism.

Authors:  Saara Metso; Pia Jaatinen; Heini Huhtala; Tiina Luukkaala; Heikki Oksala; Jorma Salmi
Journal:  Clin Endocrinol (Oxf)       Date:  2004-11       Impact factor: 3.478

7.  Ablative radioiodine therapy for hyperthyroidism: long term follow up study.

Authors:  P Kendall-Taylor; M J Keir; W M Ross
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

8.  Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.

Authors:  E Ron; M M Doody; D V Becker; A B Brill; R E Curtis; M B Goldman; B S Harris; D A Hoffman; W M McConahey; H R Maxon; S Preston-Martin; M E Warshauer; F L Wong; J D Boice
Journal:  JAMA       Date:  1998 Jul 22-29       Impact factor: 56.272

9.  Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.

Authors:  U F Willemsen; P Knesewitsch; T Kreisig; C R Pickardt; C M Kirsch
Journal:  Eur J Nucl Med       Date:  1993-11

10.  Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.

Authors:  Michael J Reinhardt; Ingo Brink; Alexius Y Joe; Dirk Von Mallek; Samer Ezziddin; Holger Palmedo; Thomas M Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-26       Impact factor: 9.236
View more
  10 in total

1.  Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

Review 2.  Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.

Authors:  Massimo Salvatori; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

3.  EANM procedure guidelines for therapy of benign thyroid disease.

Authors:  Marcel P M Stokkel; Daria Handkiewicz Junak; Michael Lassmann; Markus Dietlein; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

4.  Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders.

Authors:  Falk Gühne; Christian Kühnel; Martin Freesmeyer
Journal:  Endocrine       Date:  2017-03-07       Impact factor: 3.633

5.  Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

Authors:  Johannes W van Isselt; John M H de Klerk; Cornelis J M Lips
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

Review 6.  Efficacy of different protocols of radioiodine therapy for treatment of toxic nodular goiter: systematic review and meta-analysis of the literature.

Authors:  Haleh Rokni; Ramin Sadeghi; Zohreh Moossavi; Giorgio Treglia; Seyed Rasoul Zakavi
Journal:  Int J Endocrinol Metab       Date:  2014-04-01

7.  Comparison of clinical outcome after a fixed dose versus dosimetry-based radioiodine treatment of Graves' disease: Results of a randomized controlled trial in Indian population.

Authors:  Abhishek Kumar Jaiswal; Chandrasekhar Bal; Nishikant Avinash Damle; Sanjana Ballal; Ravinder Goswami; Smriti Hari; Praveen Kumar
Journal:  Indian J Endocrinol Metab       Date:  2014-09

8.  Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults.

Authors:  Abigail U Canto; Paulette N Dominguez; Cecilia A Jimeno; Jerry M Obaldo; Ruben V Ogbac
Journal:  Endocrinol Metab (Seoul)       Date:  2016-03

9.  Prediction of thyroidal 131I effective half-life in patients with Graves' disease.

Authors:  Ruiguo Zhang; Guizhi Zhang; Renfei Wang; Jian Tan; Yajing He; Zhaowei Meng
Journal:  Oncotarget       Date:  2017-09-12

10.  Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated 131I dose.

Authors:  Ka Kit Wong; Barry L Shulkin; Milton D Gross; Anca M Avram
Journal:  Clin Diabetes Endocrinol       Date:  2018-11-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.